Meki, Irene Kasindi
Ahn, Ki Bum
Dundon, William G.
Settypalli, Tirumala Bharani K.
Leth, Christoph
Steinrigl, Adi
Revilla-Fernández, Sandra
Schmoll, Friedrich
Ceglie, Letizia
Berete, Kouramoudou
Metlin, Artem
Dhingra, Madhur
Nowotny, Norbert
Cattoli, Giovanni
Lamien, Charles Euloge
Article History
Received: 15 November 2024
Accepted: 12 September 2025
First Online: 17 October 2025
Declarations
:
: The authors confirm that the ethical policies of the journal, as stated on the journal’s ethical guidelines, have been adhered to. The RNA samples from humans were upper respiratory swab samples collected by the Department for Molecular Biology at AGES during a screening program targeting Austrian residential/nursing homes for SARS-CoV-2. The other animal samples used in this study were those stored at the Animal Production and Health Laboratory (APHL), Seibersdorf, Austria, that were initially collected as part of routine diagnosis by the Central/National Veterinary Laboratory of Mauritania, Guinea, Ethiopia, Kuwait, Ivory Coast, Cameroon, Vietnam, Kenya, Nepal, Zambia, Mongolia, Namibia, Botswana, and Lesotho, and submitted to APHL for the characterization of other suspected diseases. The MERS-CoV samples were part of a WHO proficiency test panel, stored at Vetmeduni, Vienna. Ethical approval was not required. This study was conducted in accordance with ARRIVE guidelines.
: Not applicable.
: The authors declare no competing interests.